Table 2.
Demographic and clinical characteristics for participants of Sample B.
Adult-Onset Schizophrenia Patients and Healthy Controls | |||||||
---|---|---|---|---|---|---|---|
Patients | Healthy Controls | ||||||
Variable | (N = 40) | (N = 40) | Analysis | ||||
Mean | SD | Mean | SD | t/χ2 | df | p | |
Age (year) | 25.43 | 5.16 | 24.13 | 6.85 | 0.96 | 78 | 0.341 |
Education (year) | 11.37 | 3.36 | 15.75 | 2.23 | −6.89 | 77 | <0.001 |
Sex (M:F) | 17:23 | 13:27 | 0.85 | 1 | 0.356 | ||
Duration of illness (month) | 36.54 | 40.15 | |||||
Onset age (years) | 22.40 | 4.30 | |||||
Positive and Negative Syndrome Scale | |||||||
Positive scale score | 16.20 | 6.28 | |||||
Negative scale score | 16.48 | 9.32 | |||||
General psychopathology score | 36.78 | 13.91 | |||||
CPZ equivalents (mg) | 254.10 | 173.40 | |||||
TEPS total | 73.56 | 15.10 | 87.68 | 12.34 | −4.57 | 78 | <0.001 |
TEPS anticipatory | 32.38 | 7.69 | 38.08 | 6.30 | −3.63 | 78 | 0.001 |
TEPS consummatory | 37.38 | 9.03 | 45.50 | 7.11 | −4.47 | 78 | <0.001 |
UPSIT | 29.35 | 4.20 | 32.13 | 4.14 | −2.98 | 78 | 0.004 |
SD, Standard Deviation; M, Male; F, Female; CPZ, Chlorpromazine; TEPS, Temporal Experience of Pleasure Scale; UPSIT, The University of Pennsylvania Smell Identification Test.